Evaluation of the effect of probiotics in the treatment of jaundice
Phase 3
- Conditions
- eonatal jaundice.Hyperbilirubinaemia without mention of jaundice, not elsewhere classified
- Registration Number
- IRCT20220425054656N1
- Lead Sponsor
- Oroumia University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Semester infants with jaundice
Exclusion Criteria
Hospitalized infants with a diagnosis of jaundice who have sepsis
2 admitted with a diagnosis of jaundice who have respiratory distress
Increased jaundice with the necessary amounts for blood transfusion
Jaundice due to blood group incompatibility and RH
Direct hyperbilirubinemia
Infants with severe congenital anomalies
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method eonatal jaundice. Timepoint: 0?24?48?72 hour. Method of measurement: Bilirubin detection kit.
- Secondary Outcome Measures
Name Time Method